Original filing (PDF)20250701121703NAL0018454608001

HEMO BIOSCIENCE, INC.

Name: HEMO BIOSCIENCE, INC. — HEMO BIOSCIENCE 401(K) PLAN, Form 5500 (2024)
Creator: HEMO BIOSCIENCE, INC.

Form 5500-SF

FILING_RECEIVED

HEMO BIOSCIENCE 401(K) PLAN

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$211K

Net assets (EOY)

$211K

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for HEMO BIOSCIENCE, INC..

Plan sponsor

Name

HEMO BIOSCIENCE, INC.

EIN

20-0419100

Address

4022 STIRRUP CREEK DRIVE · SUITE 311 · DURHAM, NC · 27703

Phone

(919) 313-2888

Industry

Manufacturingsee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-07-01

Pension benefit codes

2E · Profit-sharing

3D · Pre-approved plan (master / prototype / VS)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2F · ERISA section 404(c)

2T · Default investment account (QDIA)

Audit & trust (Schedule H)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Manufacturing plans

GRYPHON BIO, INC.

GRYPHON BIO, INC. 401(K) PLAN

$213K · 4 participants

LEELHAN, P.C.

LEELHAN, P.C. 401(K) PLAN

$213K · 4 participants

RUSAT TRADING LLC

RUSAT TRADING LLC 401K PLAN

$207K · 4 participants

ATTERX BIOTHERAPEUTICS, INC.

ATTERX 401(K) PLAN

$207K · 3 participants

FAUBEL PHARMA SERVICES CORP

FAUBEL PHARMA SERVICES CORP 401(K) PROFIT SHARING PLAN & TRUST

$207K · 7 participants